Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)

BACKGROUND: In recent years, genetic factors have attracted research interest as important predisposing factors for cardiovascular susceptibility. This study aimed to investigate the influences of dual-dose clopidogrel, clopidogrel combined with tongxinluo, and ticagrelor on the platelet activity an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Chen, Shuxia, Zhang, Yi, Wang, Lili, Geng, Yanping, Gu, Jian, Hao, Qingqing, Wang, Hua, Qi, Peng
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2017
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5555704/
https://ncbi.nlm.nih.gov/pubmed/28783717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.903054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars